Pionyr Immunotherapeutics
Yunfeng Li is a Senior Director of Biostatistics at Pionyr Immunotherapeutics. Yunfeng has over 20 years of experience in the pharmaceutical industry. Yunfeng started their career as a Sr. Statistician at Wyeth Research and then held positions of Associate Director at Cerexa and Shire Pharmaceuticals before becoming a Director of Biostatistics at Pharmacyclics. Nektar Therapeutics was their next role where they led biostatistics for the oncology programs. Her current role is at Assembly Biosciences, Inc. as the Head of biostatistics leading biostatistics activities.
Yunfeng Li has a Master of Science in Statistics from Iowa State University, a Doctor of Philosophy in Mathematics from University of Science and Technology of China, and a Master of Science in Mathematics from Qufu Normal University. Yunfeng also has a Bachelor's degree in Mathematics from Sichuan University.
They are on a team with Kristen Pierce - VP, Translational Medicine, Marc Chamberlain - Senior Medical Director, and Linda Liang - VP, Protein Sciences. Their manager is Leonard Reyno, EVP & Chief Medical Officer.
This person is not in any offices
Pionyr Immunotherapeutics
Pionyr Immunotherapeutics discovers and develops first-in-class biologic drugs that fine-tune natural immune responses to increase immune defenses for diseases such as cancer, or to dampen immune responses in autoimmune diseases.